Real-time enrollment status for this clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:03 PM UTC
| NCT Number | NCT05172245 |
| Recruiting Status | Recruiting |
| Condition | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 |
| Phase | PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 17 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 22, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT05172245 is currently recruiting participants. This phase1 study for clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 is actively seeking new participants at 17 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05172245 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05172245 was last updated 2 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.